Clinical Trials Logo

Clinical Trial Summary

Greater Trochanteric Pain Syndrome (GTPS) is characterized by lateral hip pain, pain radiating to the lateral leg, tenderness and rotation around the greater trochanter, and pain with specific activities such as abduction or adduction. GTPS is primarily diagnosed clinically. Conservative treatment for GTPS includes activity modification, physiotherapy, nonsteroidal anti-inflammatory drugs, local corticosteroids, and platelet-rich plasma injections. Particularly, regional muscle sensitivity, such as in the gluteus maximus, is prominent. In recent years, dry needling therapy, which has gained popularity and increased research attention, has become an alternative treatment option, especially if the underlying cause is myofascial pain syndrome or deeper issues like piriformis syndrome. The provided text discusses dry needling as a treatment for various neuromusculoskeletal pain conditions, emphasizing its use as a minimally invasive procedure that involves applying filiform needles to the relevant muscle tissue without the administration of pharmacological drugs. The literature suggests that dry needling therapy has the ability to induce biochemical, biomechanical, endocrinological, and neurovascular changes associated with the reduction of pain and disability in individuals. However, the optimal treatment dosage has not yet been determined, and there is inconsistency in the literature regarding the number of needles to be inserted and the duration of needle retention. Studies evaluating the effectiveness of dry needling are often designed to compare or add it to other injection therapies. Additionally, there is a limited number of studies conducted with real-time imaging. In the planned study, the use of ultrasound-guided dry needling aims to provide a sham application opportunity, where the patient is blinded to the nature of the procedure, allowing for a meaningful investigation of efficacy. This aspect of the study is expected to contribute significantly to the literature.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06241872
Study type Interventional
Source Kutahya Health Sciences University
Contact Hasan H Gökpinar, Ass. Prof.
Phone +905052842222
Email hasanhuseyin.gokpinar@ksbu.edu.tr
Status Recruiting
Phase N/A
Start date February 20, 2024
Completion date May 15, 2024

See also
  Status Clinical Trial Phase
Completed NCT03479190 - Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial) N/A
Terminated NCT05486078 - Evaluation of the Efficacy of the Use MD Tissue Collagen Medical Device in the Infiltrative Treatment of Greater Trochanter Pain Syndrome (GTPS) N/A
Recruiting NCT06026579 - Clinical Characteristics and Subgroups in Greater Trochanteric Pain Syndrome
Recruiting NCT05086926 - Feasibility of Home Exercises With the Addition of a Corticosteroid Injection in Patients With Lateral Hip Pain in General Practice N/A
Not yet recruiting NCT05076994 - The PET Project: Patient Education Tool for Home Exercise N/A
Recruiting NCT05516563 - LEAP-Ireland Feasibility Trial of Exercise and Education for Gluteal Tendinopathy N/A
Not yet recruiting NCT02031367 - Efficacy of Platelet Rich Plasma vs. Corticosteroid Injections for Treating Greater Trochanteric Pain Syndrome Phase 0
Completed NCT01642043 - Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome
Not yet recruiting NCT05710627 - Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS) N/A
Completed NCT03720587 - The Experiences of Patients With Greater Trochanteric Pain Syndrome.
Completed NCT04537091 - Radial Extracorporeal Shock Wave Therapy Versus Platelet-rich Plasma Injection for Greater Trochanteric Pain Syndrome N/A
Completed NCT01562366 - Research Study to Compare the Addition of Topaz Micro Debridement to the Standard of Care Surgery N/A